411 related articles for article (PubMed ID: 37407110)
1. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB
J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110
[TBL] [Abstract][Full Text] [Related]
2. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
[TBL] [Abstract][Full Text] [Related]
4. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
[TBL] [Abstract][Full Text] [Related]
5. 5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease.
Garcia S; Cubeddu RJ; Hahn RT; Ternacle J; Kapadia SR; Kodali SK; Thourani VH; Jaber WA; Asher CR; Elmariah S; Makkar R; Webb JG; Herrmann HC; Lu M; Devireddy CM; Malaisrie SC; Smith CR; Mack MJ; Sorajja P; Cavalcante JL; Goessl M; Shroff GR; Leon MB; Pibarot P
JACC Cardiovasc Interv; 2021 Sep; 14(18):1995-2005. PubMed ID: 34556273
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
[TBL] [Abstract][Full Text] [Related]
7. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB
Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442
[TBL] [Abstract][Full Text] [Related]
11. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
[TBL] [Abstract][Full Text] [Related]
12. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S
Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204
[TBL] [Abstract][Full Text] [Related]
14. Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement.
Abbas AE; Ternacle J; Pibarot P; Xu K; Alu M; Rogers E; Hahn RT; Leon M; Thourani VH
Circ Cardiovasc Imaging; 2021 Aug; 14(8):e012364. PubMed ID: 34387097
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
Thyregod HGH; Jørgensen TH; Ihlemann N; Steinbrüchel DA; Nissen H; Kjeldsen BJ; Petursson P; De Backer O; Olsen PS; Søndergaard L
Eur Heart J; 2024 Apr; 45(13):1116-1124. PubMed ID: 38321820
[TBL] [Abstract][Full Text] [Related]
17. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts.
Szerlip M; Gualano S; Holper E; Squiers JJ; White JM; Doshi D; Williams MR; Hahn RT; Webb JG; Svensson LG; Kirtane AJ; Cohen DJ; Douglas PS; Alu MC; Crowley A; Tuzcu EM; Makkar RR; Herrmann HC; Babaliaros V; Thourani VH; Leon MB; Kodali SK; Mack MJ
JACC Cardiovasc Interv; 2018 Jan; 11(1):13-20. PubMed ID: 29301644
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve replacement using the SAPIEN 3 valve versus surgical aortic valve replacement using the rapid deployment INTUITY valve: Midterm outcomes.
Useini D; Beluli B; Christ H; Schlömicher M; Ewais E; Haldenwang P; Patsalis P; Moustafine V; Bechtel M; Strauch J
J Card Surg; 2021 Feb; 36(2):610-617. PubMed ID: 33386755
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
20. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
Pibarot P; Weissman NJ; Stewart WJ; Hahn RT; Lindman BR; McAndrew T; Kodali SK; Mack MJ; Thourani VH; Miller DC; Svensson LG; Herrmann HC; Smith CR; Rodés-Cabau J; Webb J; Lim S; Xu K; Hueter I; Douglas PS; Leon MB
J Am Coll Cardiol; 2014 Sep; 64(13):1323-34. PubMed ID: 25257633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
